Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects

Trivedi, A; Mackowski, M; Jafarinasabian, P; Zhang, HZ; Flach, S; Terminello, B; Bhatia, A; Dutta, S; Lee, E

Trivedi, A (corresponding author), Amgen Inc, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.

CLINICAL DRUG INVESTIGATION, 2021; 41 (7): 639

Abstract

Background and Objective Omecamtiv mecarbil (OM) is a cardiac myosin activator under clinical development for the treatment of heart failure. Two modi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索